Bradmer intends to complete private placement of common shares

Bradmer Pharmaceuticals Inc. (NEX: BMR.H) ("Bradmer" or the "Corporation") announced today that it intends to complete a private placement of up to 5,263,157 common shares at a price of $0.095 per share, for aggregate gross proceeds to the Corporation of up to $500,000.00 (the "Offering").

The proceeds of the Offering will be used primarily for general corporate purposes. Completion of the financing is subject to the approval of the NEX Board of the TSX Venture Exchange (the "NEX"). The common shares issued pursuant to the Offering will be subject to a hold period expiring four months and one day after the closing date of the Offering.